|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Other receivable | ||||||||||||||||||||
| Insurance receivable | ||||||||||||||||||||
| Investment in equity securities | ||||||||||||||||||||
| Prepaids and other assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| OTHER ASSETS | ||||||||||||||||||||
| Definite-life intangible assets | ||||||||||||||||||||
| Indefinite life intangible assets, net | ||||||||||||||||||||
| Definite life intangible assets, net | ||||||||||||||||||||
| Software platform, net | ||||||||||||||||||||
| Trademarks, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deposits and other assets | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Total Other Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable – trade | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Contingent consideration liability | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Stock subscription payable | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Notes payable – related parties, net | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| NON-CURRENT LIABILITIES: | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Contingent consideration liability, noncurrent (Note 3) | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Total Non-Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; 8 shares designated as Series B Convertible Preferred Stock, all of which were issued and outstanding at June 30, 2026; no shares issued and outstanding at June 30, 2025 | ||||||||||||||||||||
| Common stock, par value $0.0001, 350,000,000 shares authorized, 4,615,503 shares issued and outstanding at June 30, 2026; 2,217,411 shares issued and outstanding at June 30, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive (loss) | ||||||||||||||||||||
| Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
Loading...
